[Top] [All Lists]

[e-drug] Summer Courses Utrecht, The Netherlands 2018

E-DRUG: Summer Courses Utrecht, The Netherlands 2018

Dear colleagues,

This summer, the Division of Pharmacoepidemiology and Clinical Pharmacology at 
Utrecht University, the Netherlands, offers you again three challenging 
international summer courses:

2 -6 July 2018 - Pharmacoepidemiology & Drug safety

9-13 July 2018 - Pharmaceutical Policy Analysis (organized by the WHO CC 
Pharmaceutical Policy and regulation in collaboration with WHO)

16-20 July 2018 - Pharmacoeconomics

All courses will cover the key issues in each field and focus on the most 
important research methods used. All course teachers have extensive expertise 
in their field. More detailed information can be found below or on the summer 
school website (www.utrechtsummerschool.nl<http://www.utrechtsummerschool.nl>). 
Registration takes place through this website as well. Our experience is that 
courses fill up quickly, so register as soon as possible.

A few scholarships are available for the Pharmaceutical Policy Analysis course 
for participants from low and middle income countries. These scholarships 
include course fee and basic student housing as described on the summer school 
website. International travel is at the expense of the applicant or his/her 
institution. If you wish to apply for a scholarship, please do so before 22 
April 2018 by sending an application letter including motivation plus CV to
 Rianne van den Ham   h.a.vandenham@uu.nl
All applicants will be notified by 11 May 2018.

Supplementary, there is a cultural and social programme arranged for you to 
make sure that you experience the best of Utrecht. We look forward to welcoming 

M7 Pharmaceutical Policy Analysis (9-13 July 2018)

Medicines are among the most regulated products in society. From the earliest 
pre-clinical stages onward, policy makers want to foster the development of 
safe, effective and affordable medicines for patients in need of 
pharmacotherapy. When a drug reaches the market, it is the beginning of a 
process of complex interactions between patients, prescribers, insurers, 
pharmaceutical companies and governments. Furthermore, the inequity in access 
to medicines is still a defining characteristic of the global pharmaceutical 
market place.

The aim of the course is to give students insight into current developments in 
pharmaceutical policy making as well to give a better understanding of the 
methods available for analysing the effects of policy interventions. As a 
collaborator on this course, the World Health Organization will provide faculty 
for several of the sessions.

You will experience an intensive programme covering the following topics:
Pharmaceutical Policy Analysis issues and methods; current challenges in drug 
innovation;  universal health coverage; regulatory issues and challenges; 
country profiles;  policy and politics; synthesis, case studies & public health.

Course directors
Prof. Dr. Bert Leufkens, Prof. Dr. Aukje, Mantel, Dr. Rianne van den Ham and 
Dr. Gilles Forte (WHO)

M8 Pharmacoepidemiology & Drug Safety (2-6 July 2018)

With the prospect that innovative drug therapies will be introduced in the 
coming years, society demands new approaches and concepts for comparative 
risk/benefit evaluation. Assessment of safety and risk management of different 
drug therapies is done in the framework of observational epidemiological 
studies (proof of safety, proof of effectiveness). This is the logical next 
step after randomized clinical trials, which are designed to provide evidence 
of a drugs efficacy.

The course will cover key issues in pharmacoepidemiologic and drug safety 
research. Special topics include databases and molecular pharmacoepidemiology.  
Students will learn about the typical problems (e.g. confounding by indication, 
rare side effects) and approaches to deal with these problems in the practice 
of pharmacoepidemiology.

You will experience an intensive programme covering the following topics: Study 
Design and Methods; Confounding and other biases; Methods in drug safety 
research; drug safety and risk management; overview of pharmacoepidemiological 
databases; molecular pharmacoepidemiology; drug utilization research; 
synthesis, case studies & public health.

Course director
Prof. O.H. Klungel

Prof. S. Suissa, Prof. H.G.M. Leufkens, Prof. A. de Boer, Prof. A.C.G. Egberts, 
Prof. T.P. van Staa, Dr. F. de Vries

M14 Pharmacoeconomics (16-20 July 2018)

Today's society is confronted with ever increasing health care costs. One of 
the factors is the cost of drug innovations. Diseases waiting for therapeutic 
solutions are complicated and multifactorial in nature. As a result, drug 
innovation has become even more complex leading to high tech and therefore high 
cost solutions. The question arises, what is the added value of such high cost 
innovations and how can it be determined when both benefit and harm are 
considered. Health economics, and more specific pharmacoeconomics, aims to 
provide a neutral scientific approach to this challenge.

This course aims to provide a broad perspective of the field, including a 
variety of subjects from views of the different stakeholders to more in depth 
methodological approaches, illustrated with examples and exercises.

You will experience an intensive programme covering the following topics: 
pharmacoeconomic techniques; study designs and methods; critical appraisal of 
pharmacoeconomic studies; the (im)possibilities of the use of HTA and 
pharmacoeconomics in regulatory decisions; the economics of personalized 
medicine; pharmacoeconomics of orphan drugs.

Course director
Dr. Anke Hövels

Prof. Dr. Bert Leufkens, Dr. Geert Frederix, Dr. Saskia Knies, Dr. Wim Goettsch 
among others

General information for all courses

Target groups
(Post)graduates and professionals within governments, NGOs, industry, 
universities with a basic knowledge public health/medicine who have an interest 
in the policy aspects of pharmaceuticals, pharmacoepidemiology  and/or 

Fee and combinations
Euro�975,- per course (including course materials + lunches + course dinner, 
excluding housing). Combination fee for two courses is  Euro �1550,- (excluding 
housing), combination fee for all three courses combined is Euro �2025,- 
(excluding housing).

Deadline for application
17 June 2018, see www.utrechtsummerschool.n<http://www.utrechtsummerschool.nl>l 
(information summer school and course registration)

More information
Course coordinator: Nienke Op 't Hoog (pharm.summercourses@gmail.com)

On behalf of the other course directors,

Best wishes,
Rianne van den Ham
<Prev in Thread] Current Thread [Next in Thread>
  • [e-drug] Summer Courses Utrecht, The Netherlands 2018, Ham, H.A. van den (Rianne) <=